References
- Buckley N. A., Whyte I. M., Dawson A. H. Cardiotoxicity more common in thioridazine overdose than other neuroleptics. J Toxicol Clin Toxicol 1995; 33: 199–204
- Martensson E., Nyberg G., Axellson R., Serck-Hansen K. Quantitative determination of thioridazine and nonconjugated thioridazine metabolites in serum and urine of psychiatric patients. Curr Ther Res 1975; 18: 687–700
- Gottschalk L. A., Dinovo E., Biener R., Nandi B. R. Plasma concentrations of thioridazine metabolites and ECG abnormalities. J Pharm Sci 1978; 67: 155–157
- Axelsson R., Martensson E. Side effects of thioridazine and their relationship with the serum concentrations of the drug and its main metabolites. Curr Ther Res 1980; 28: 463–489
- Poklis A., Wells C. E., Juenge E. C. Thioridazine and its metabolites in post mortem blood, including two stereoisomeric ring sulfoxides. J Anal Toxicol 1982; 6: 250–252
- Hale P. W., Poklis A. Thioridazine 5-sulfoxide diastereoisomers in serum and urine from rats and man after chronic thioridazine administration. J Anal Toxicol 1985; 9: 197–201
- Hale P. W., Poklis A. Cardiotoxicity of thioridazine and two stereoisomeric forms of thioridazine 5-sulfoxide in the isolated perfused rat heart. Toxicol Appl Pharmacol 1986; 86: 44–55
- Heath A., Svensson C., Martensson E. Thoridazine toxicity - an experimental cardiovascular study of thioridazine and its majer metabolites in overdose. Vet Hum Toxicol 1985; 27: 100–105
- Hale P. W., Melethil S., Poklis A. The disposition and elimination of stereoisomeric pairs of thioridazine 5-sulfoxide in the rat. Eur J Drug Metab Pharmacokinet 1985; 10: 333–341
- Hale P. W., Poklis A. Determination of diastereoisomeric pairs of thioridazine 5-sulfoxide by high-performance liquid chromatography. J Chromatogr 1984; 336: 452–455